A prevalent and economically important inflammatory condition that affects dairy cows' mammary glands is called bovine mastitis. Although bacterial infections are the main cause, fungi, viruses, and physical trauma can also cause it. There are two types of mastitis: subclinical (which has no outward symptoms but can be identified by somatic cell counts) and clinical (which has outward symptoms such swelling, fever, pain, and abnormal milk).  The illness results in lower milk production, lower-quality milk, and more labour and treatment expenses.  In order to ensure the health and production of dairy herds, effective mastitis management entails maintaining appropriate hygiene, early diagnosis, and prompt treatment.

According to SPER Market Research, ‘Global Bovine Mastitis Market Size- By Product, By Route of Administration, By Therapy, By Type, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Bovine Mastitis Market is predicted to reach 4.05 billion by 2034 with a CAGR of 8.32%.

Drivers:

Demand for dairy products is increasing due to a growing global population and increased disposable incomes. This, in turn, is increasing demand for healthier dairy cows and more productive milk production.  Effective mastitis management is therefore highly valued in the dairy industry. Dairy producers' increasing awareness of the detrimental impacts mastitis has on their health and the economy is also helping to promote the use of preventive and treatment strategies. Furthermore, the use of diagnostic tools allows for the accurate and timely identification of the microbes that cause mastitis. These advancements are significantly expanding the market for bovine mastitis, especially when paired with the development of innovative therapeutic alternatives including non-antibiotic therapy.

Request a Free Sample Report: https://www.sperresearch.com/report-store/bovine-mastitis-market?sample=1

Restraints:

Clinical or subclinical mastitis drastically lowers milk production and has a negative impact on the productivity of the dairy sector as well as the income of farmers. By reducing essential components including lactose, fat, and casein, it changes the composition of milk, lowering yield and compromising quality. This lowers the market value and makes processing dairy products like cheese more difficult. Dairy operations are further burdened financially by the expense of treatment, which includes veterinarian care, prescription drugs, and additional labour for caring for afflicted cows. Therefore, it is crucial to prevent and control mastitis since it poses economic and productivity issues for dairy farmers. Due to the increasing number of cattle and the need to satisfy customer demands for sustainable animal protein sources, the North American bovine mastitis market had the greatest revenue share. Mastitis has a major effect on milk output and quality. Maintaining output, satisfying the growing demand for animal protein worldwide, and achieving environmental objectives all depend on preventing or successfully managing this disease. Some of the key market players are Ceva, Elanco, Forte Healthcare Ltd, Heilsaa, HIPRA, Immucell Corporation, and others.

For More Information, refer to below link: –   

Bovine Mastitis Market Share

Related Reports:

Cell Therapy Raw Materials Market Growth

Hydronephrosis Treatment Market Growth

Follow Us –  

LinkedIn | Instagram | Facebook | Twitter  

Contact Us:  

Sara Lopes, Business Consultant — USA  

SPER Market Research  

enquiries@sperresearch.com  

+1–347–460–2899